N/A N=31 Validity of the PortionSize App to Measure Children's Food Intake
Nutritional Assessment
Primary: Estimation of Energy Intake (kcal) by Children Using the PortionSize App — 717.9 kcal — p=0.022
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=9 Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
Clostridium Difficile Infection · Hematologic Diseases · Bone Marrow Transplant
Primary: Changes in Clostridium Difficile Bacterial Loads in the Stool — 62102500.00; 40000000.00; 7752750.00; 185000.00 CFUs
N/A N=96 Postoperative Opioid Consumption in Gastric Sleeve Surgery
Obesity &Amp; Overweight · General Anesthetic · Ketamine
Primary: Morphine Equivalent Opioid Consumption — 40; 30 miligram
Phase 1 N=24 Study of the Effect of HFA-152a and HFA-134a Propellants on Mucociliary Clearance in Healthy Participants
Asthma
Primary: Area Under the Percent Radiolabeled Particle Retention-time Curve up to 4 Hours [AUC(0-4h)] After Nebulized 99mTechnetium (99mTc) Inhalation on Day 7 — 351.57; 351.76…
N/A N=372 Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation
Hematologic Diseases
Primary: Caregiver Health-related Quality of Life (HRQOL) Assessed by the PROMIS Global Health Scale. — 48.18; 48.16 score on a scale
Phase 2 N=5 Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Supplemental Open-Label Arm
Parkinsonian Signs in Older Persons
Primary: Average Gait Speed — 0.81; 0.86; 0.86 meters per second
N/A N=188 Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults
Diabetes Mellitus, Type 1
Primary: Change in HbA1c (%) — 8.13; 8.10; 7.20; 8.00 Percentage of HbA1C
Phase 2 N=67 Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT)
Gastric Cancer by AJCC V8 Stage · Resectable Carcinoma
Primary: Pathologic Response After Pre-operative Treatment — 20 Participants
Phase 3 N=396 Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea
Diarrhea · Cholera
Primary: Stool Output — 4769; 4742; 1688; 1704 gram — p=0.9941
Phase 2 N=33 Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)
Fabry Disease
Primary: Incidence of Treatment-emergent Adverse Events (TEAEs) - All — 2; 2; 3; 2 Participants
N/A N=85 Effectiveness of Core Stability Exercises on Foot Posture, Function and Limb Alignment in Flexible Flat Feet Patients
Flexible Flatfoot
Primary: Staheli Plantar Arch Index (SPAI) — -0.18; -0.03; -0.138; -0.036 Millimeters (mm) — p=<0.001
Phase 2 N=32 INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)
Respiratory Papillomatosis
Primary: Percentage of Participants With at Least One Treatment-Emergent Adverse Events (TEAEs) and Serious TEAEs — 33.3; 66.7; 75.0; 62.5 percentage of participants
N/A N=37 Study of a Prototype Software to Help Surgical Patients Manage Their Pain Medication
Post-operative Situation
Primary: Rate of Agreement Between the Recommendations of the INSAMED Computer Tool and the Recommendations Made by a Healthcare Professional From the Research Team Based on the…
N/A N=60 Empowering Preschool Children With Personal Safety Skills
Safety · Preschool Age Children · Self Administration
Primary: Change in Health Education Scale- Personal Safety and First Aid Subscale (PSFAS) Score — 108.93; 105.45; 103.27; 103.89 score — p=0.027
Phase 2 N=55 Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma
Musculoskeletal Injury
Primary: BDI-II - Beck Depression Inventory-II — 11.4; 12.8; 9.6; 11.5 units on a scale